Narrow, unimaginative public health responses inhibit reducing HIV, exploitation and marginalisation within sex work.
Articles on HIV
Displaying 141 - 160 of 434 articles
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
New research highlights how the press excluded, shamed and invaded the privacy of those living with HIV.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
COVID-19 restrictions created life-threatening challenges to female sex workers as they weren’t able to access their medication, support or their clients.
Local and national governments in west and central African countries must prioritise investment in providing access to HIV testing for all pregnant women.
The evidence shows that keeping girls in school not only reduces HIV risk, but also delays marriage and pregnancy, and improves mental health.
In both countries, neglect and misinformation at the highest levels of government led to undue tragedy.
Parents have the primary role of educating their children about their sexuality. But cultural beliefs and taboos about sex can work strongly against their efforts.
The HIV/AIDS response played out over a much longer trajectory than COVID-19. But it is, in some respects, a shining example of what can be achieved when countries and people work together.
If the world is single-minded and focuses purely on combating one pandemic, forgetting others, the effects of other morbidity and mortality on healthcare systems will be seen for a long time to come.
Nurses represent 50% of the global healthcare workforce. And they are often the sole healthcare providers in many low and middle-income countries.
Care for patients with more than one disease is fragmented and uncoordinated. This is can cost patients time, effort and lost wages.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
Our findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.
To better anticipate and manage the emergence of new pandemics, a paradigm shift is needed to take into account the complex interactions between human health, animal health, the environment and the economy.
Equipping parents with the right information on what to talk about, and how to talk about it, is a key step in addressing challenges to sexual health.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
The use of antiretroviral therapy among pregnant and breastfeeding women in Zambia has increased but adherence is a problem.
Top contributors
-
Associate Professor, Public Health Ethics, School of Population Health, UNSW
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Distinguished Professor, Infectious Disease and Oncology Research Institute, Faculty of Heath Sciences, University of the Witwatersrand, Executive Director Perinatal HIV Research Unit, Chief Scientific Officer, South African Medical Research Council
-
Melbourne Laureate Professor, University of Melbourne; Director, The Peter Doherty Institute for Infection and Immunity
-
Principal Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Doctoral Researcher, School of Public Health and Public Health Technical Advisor, Anova Health Institute, University of the Witwatersrand
-
Assistant Professor of Public Health, University of Iowa
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Associate Professor, Monash University
-
Research Director at The Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Research Scientist, African Population and Health Research Center
-
Professor of Gender Studies, Chair in Sex Media and Sex Cultures, Linköping University
-
Scientia Professor of Medicine and Director, Kirby Institute, UNSW